Oxygen Versus PAP for Sleep Apnea in Heart Failure (OPTIMAL-HF)
Oxygen Versus PAP for Treatment of Sleep Apnea in Chronic Heart Failure
Sponsor: VA Office of Research and Development
A PHASE4 clinical study on Heart Failure and Sleep Apnea Syndromes, this trial is completed. The trial is conducted by VA Office of Research and Development and has accumulated 16 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2022 — Feb 2023 [monthly]
Completed PHASE4
-
Apr 2022 — Sep 2022 [monthly]
Completed PHASE4
▶ Show 11 earlier versions
-
Sep 2021 — Apr 2022 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Mar 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
-
Feb 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Aug 2019 — Feb 2020 [monthly]
Recruiting PHASE4
-
Jan 2019 — Aug 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .